CF drug may cost €230k per patient

Concerns have been raised that a new wonder drug for cystic fibrosis (CF) patients could be prohibitively expensive as manufacturers are seeking to charge up to €230,000 per patient for a one year supply of the pills.

Kalydeco — the first ever drug to treat the root causes of CF — was approved for usage by the European Medicines Agency in the summer.

Discussions between the health authorities and the drug manufacturer, Vertex, about cost, have been taking place.